Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions.

52W Range

54thpctl

Volume

0.83×avg

Market Cap

1.08BUSD

P/E Ratio

-9.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Savara Inc.

SVRANASDAQ Global Select·USD·Closed

Savara Inc.

SVRANASDAQ·USD·Closed

$5.26

−4.19%

$5.26

−$0.23 (4.19%)

52W Range

54thpctl

Volume

0.83×avg

Mkt Cap

1.08BUSD

P/E

-9.1TTM

Div Yield

–ann

SVRA: Savara Inc. Stock Analysis | finqOS